ASCO 2019 | Updates from the ZUMA-8 trial: KTE-X19 for R/R CLL

Ian Flinn

Ian Flinn, MD, PhD, from Tennessee Oncology, Nashville, TN, discusses the ZUMA-8 trial (NCT03624036) looking at KTE-X19 for R/R chronic lymphocytic leukemia (CLL). This interview was recorded at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.

Share this video  
Similar topics